Literature DB >> 212521

Prostanglandins enhance spread of herpes simplex virus in cell cultures.

D A Harbour, W A Blyth, T J Hill.   

Abstract

Stimuli such as u.v. light or trauma which induce recurrence of herpes simplex may act by affecting virus replication in the skin. Such stimuli release pharmacologically active agents in the skin, including prostaglandins (PGs) such as PGE2. These agents, and other compounds which alter levels of adenosine cyclic monophosphate (cyclic AMP), were tested for their effect on the replication of herpes simplex virus (HSV) in Vero cells. Prostanglandin E2 (PGE2) and prostaglandin F2alpha both increase the size of HSV plaques; PGE2 also increases the yield of virus inoculated at low m.o.i. Moreover, inhibitors of prostanglandin synthesis decrease plaque size and inhibit the growth of virus inoculated at low m.o.i.; such inhibition can be partially overcome by adding PGE2. Analysis of the results suggest that prostaglandins can enhance cell-to-cell spread of HSV, but that cyclic AMP is probably not involved in this effect.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212521     DOI: 10.1099/0022-1317-41-1-87

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

Review 1.  Current and potential treatments for ubiquitous but neglected herpesvirus infections.

Authors:  Jonathan E Gable; Timothy M Acker; Charles S Craik
Journal:  Chem Rev       Date:  2014-10-02       Impact factor: 60.622

Review 2.  The pathogenesis of acute, latent and recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

3.  Antiviral activity of a synthetic analog of prostaglandin A in mice infected with influenza A virus.

Authors:  M G Santoro; C Favalli; A Mastino; B M Jaffe; M Esteban; E Garaci
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  The effects of ultraviolet irradiation of the skin on herpes simplex virus infection: alteration in immune function mediated by epidermal cells and in the course of infection.

Authors:  T Otani; R Mori
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

5.  A latent infection of herpes simplex virus type 2 in a human neuroblastoma cell line IMR-32.

Authors:  Y Yura; K Terashima; H Iga; T Yanagawa; H Yoshida; Y Hayashi; M Sato
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

6.  Oncolytic herpes simplex virus 1 encoding 15-prostaglandin dehydrogenase mitigates immune suppression and reduces ectopic primary and metastatic breast cancer in mice.

Authors:  Jason D Walker; Inder Sehgal; Konstantin G Kousoulas
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

7.  16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.

Authors:  M Abecassis; J A Falk; L Makowka; V J Dindzans; R E Falk; G A Levy
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

8.  Effects of dimethyl prostaglandin A1 on herpes simplex virus and human immunodeficiency virus replication.

Authors:  M Hughes-Fulford; M S McGrath; D Hanks; S Erickson; L Pulliam
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

9.  Effect of prostaglandins and cyclic adenosine 3',5'-monophosphate modulators on herpes simplex virus growth and interferon response in human cells.

Authors:  K F Trofatter; C A Daniels
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

10.  A famciclovir + celecoxib combination treatment is safe and efficacious in the treatment of fibromyalgia.

Authors:  William L Pridgen; Carol Duffy; Judy F Gendreau; R Michael Gendreau
Journal:  J Pain Res       Date:  2017-02-22       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.